ArticleCurrent protocols2026
Protocol for Designing and Interpreting Minigene Assays to Validate Candidate Splice-Altering Variants Using Long-read Sequencing.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Variants affecting RNA splicing are a major contributor to human disease, yet determining the functional consequences of candidate splice-altering variants remains challenging, particularly for variants located outside canonical splice motifs. Although computational prediction tools have improved identification of potentially spliceogenic variants, experimental validation is often required to determine their impact on transcript processing. Minigene assays provide a practical and controlled approach for functional assessment, particularly when patient-derived RNA is unavailable or genes are not expressed in accessible tissues. This article describes a workflow for the design, generation, and interpretation of minigene assays for evaluation of candidate splice-altering variants. The protocol includes locus-specific insert design, commercial gene synthesis, transient transfection into cultured cells, transcript amplification, and long-read Oxford nanopore sequencing for full-length splice isoform analysis. Particular emphasis is placed on preserving sufficient local splicing context while maintaining constructs compatible with efficient plasmid synthesis and mammalian cell transfection. Compared with traditional minigene workflows relying primarily on gel electrophoresis and Sanger sequencing, long-read sequencing enables direct single-molecule resolution of complete transcript isoforms, including combinations of exon skipping, intron retention, cryptic splice site activation, and partial exon usage. This workflow provides a scalable and practical framework for functional validation of candidate splice-altering variants in research and diagnostic settings. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Design and generation of minigene constructs Basic Protocol 2: Cell transfection, RNA extraction, and cDNA amplification Basic Protocol 3: Long-read sequencing and analysis of splice isoforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.